119 related articles for article (PubMed ID: 31557609)
1. Synthesis and in-vitro anti-HIV-1 evaluation of novel pyrazolo[4,3-c]pyridin-4-one derivatives.
Kumar S; Gupta S; Abadi LF; Gaikwad S; Desai D; Bhutani KK; Kulkarni S; Singh IP
Eur J Med Chem; 2019 Dec; 183():111714. PubMed ID: 31557609
[TBL] [Abstract][Full Text] [Related]
2. Molecular modeling, synthesis and biological evaluation of N-heteroaryl compounds as reverse transcriptase inhibitors against HIV-1.
Singh A; Yadav D; Yadav M; Dhamanage A; Kulkarni S; Singh RK
Chem Biol Drug Des; 2015 Mar; 85(3):336-47. PubMed ID: 25055732
[TBL] [Abstract][Full Text] [Related]
3. Rational design and synthesis of novel thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Murugesan V; Makwana N; Suryawanshi R; Saxena R; Tripathi R; Paranjape R; Kulkarni S; Katti SB
Bioorg Med Chem; 2014 Jun; 22(12):3159-70. PubMed ID: 24794742
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and molecular docking of pyrazolo [3,4d] thiazole hybrids as potential anti-HIV-1 NNRT inhibitors.
Kasralikar HM; Jadhavar SC; Goswami SV; Kaminwar NS; Bhusare SR
Bioorg Chem; 2019 May; 86():437-444. PubMed ID: 30771690
[TBL] [Abstract][Full Text] [Related]
5. Non Nucleoside Reverse Transcriptase Inhibitors, Molecular Docking Studies and Antitubercular Activity of Thiazolidin-4-one Derivatives.
Chitre TS; Patil SM; Sujalegaonkar AG; Asgaonkar KD; Khedkar VM; Garud DR; Jha PC; Gaikwad SY; Kulkarni SS; Choudhari A; Sarkar D
Curr Comput Aided Drug Des; 2019; 15(5):433-444. PubMed ID: 30574853
[TBL] [Abstract][Full Text] [Related]
6. Fused heterocyclic compounds bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 1: design, synthesis and biological evaluation of novel 5,7-disubstituted pyrazolo[1,5-a]pyrimidine derivatives.
Tian Y; Du D; Rai D; Wang L; Liu H; Zhan P; De Clercq E; Pannecouque C; Liu X
Bioorg Med Chem; 2014 Apr; 22(7):2052-9. PubMed ID: 24631361
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis and In Vitro Evaluation of Novel Anti-HIV 3-Pyrazol-3- yl-Pyridin-2-One Analogs.
Kumar S; Gupta S; Gaikwad S; Abadi LF; Bhutani LKK; Kulkarni S; Singh IP
Med Chem; 2019; 15(5):561-570. PubMed ID: 30398119
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus.
Mao C; Sudbeck EA; Venkatachalam TK; Uckun FM
Antivir Chem Chemother; 1999 Sep; 10(5):233-40. PubMed ID: 10574178
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives targeting the entrance channel of NNRTI binding pocket.
Yang J; Chen W; Kang D; Lu X; Li X; Liu Z; Huang B; Daelemans D; Pannecouque C; De Clercq E; Zhan P; Liu X
Eur J Med Chem; 2016 Feb; 109():294-304. PubMed ID: 26802545
[TBL] [Abstract][Full Text] [Related]
10. Pyrazole NNRTIs 1: design and initial optimisation of a novel template.
Mowbray CE; Burt C; Corbau R; Perros M; Tran I; Stupple PA; Webster R; Wood A
Bioorg Med Chem Lett; 2009 Oct; 19(19):5599-602. PubMed ID: 19709880
[TBL] [Abstract][Full Text] [Related]
11. Design of annulated pyrazoles as inhibitors of HIV-1 reverse transcriptase.
Sweeney ZK; Harris SF; Arora SF; Javanbakht H; Li Y; Fretland J; Davidson JP; Billedeau JR; Gleason SK; Hirschfeld D; Kennedy-Smith JJ; Mirzadegan T; Roetz R; Smith M; Sperry S; Suh JM; Wu J; Tsing S; Villaseñor AG; Paul A; Su G; Heilek G; Hang JQ; Zhou AS; Jernelius JA; Zhang FJ; Klumpp K
J Med Chem; 2008 Dec; 51(23):7449-58. PubMed ID: 19007201
[TBL] [Abstract][Full Text] [Related]
12. 2,6-Di(arylamino)-3-fluoropyridine Derivatives as HIV Non-Nucleoside Reverse Transcriptase Inhibitors.
Sergeyev S; Yadav AK; Franck P; Michiels J; Lewi P; Heeres J; Vanham G; Ariën KK; Vande Velde CM; De Winter H; Maes BU
J Med Chem; 2016 Mar; 59(5):1854-68. PubMed ID: 26785139
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-HIV activity of some heterodimers [NRTI]-glycyl-succinyl-[trovirdine analogue] of known HIV-1 reverse transcriptase inhibitors.
Sugeac E; Fossey C; Ladurée D; Schmidt S; Laumond G; Aubertin AM
J Enzyme Inhib Med Chem; 2003 Apr; 18(2):175-86. PubMed ID: 12943202
[TBL] [Abstract][Full Text] [Related]
14. Development of nonnucleoside HIV reverse transcriptase inhibitors.
Tucker TJ; Lumma WC; Culberson JC
Methods Enzymol; 1996; 275():440-72. PubMed ID: 9026654
[No Abstract] [Full Text] [Related]
15. Design, synthesis, and biological evaluation of novel 2H-pyran-2-one derivatives as potential HIV-1 reverse transcriptase inhibitors.
Defant A; Mancini I; Tomazzolli R; Balzarini J
Arch Pharm (Weinheim); 2015 Jan; 348(1):23-33. PubMed ID: 25523431
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of dihydroquinazoline-2-amines as potent non-nucleoside reverse transcriptase inhibitors of wild-type and mutant HIV-1 strains.
Jin K; Sang Y; Han S; De Clercq E; Pannecouque C; Meng G; Chen F
Eur J Med Chem; 2019 Aug; 176():11-20. PubMed ID: 31091477
[TBL] [Abstract][Full Text] [Related]
17. Discovery of piperidine-linked pyridine analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Chen X; Li Y; Ding S; Balzarini J; Pannecouque C; De Clercq E; Liu H; Liu X
ChemMedChem; 2013 Jul; 8(7):1117-26. PubMed ID: 23650275
[TBL] [Abstract][Full Text] [Related]
18. [Design, synthesis and biologic evaluation of diarylbenzimidazole derivatives as novel HIV-1 non-nucleoside reverse transcriptase inhibitors].
Qin BJ; Zhou T; Lu H; Jiang SB; Xie L
Yao Xue Xue Bao; 2009 Nov; 44(11):1233-43. PubMed ID: 21355324
[TBL] [Abstract][Full Text] [Related]
19. Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1.
Jin K; Yin H; De Clercq E; Pannecouque C; Meng G; Chen F
Eur J Med Chem; 2018 Feb; 145():726-734. PubMed ID: 29353724
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Anti-HIV Evaluation of Novel Triazine Derivatives Targeting the Entrance Channel of the NNRTI Binding Pocket.
Chen X; Meng Q; Qiu L; Zhan P; Liu H; De Clercq E; Pannecouque C; Liu X
Chem Biol Drug Des; 2015 Jul; 86(1):122-8. PubMed ID: 25358434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
